Rudolph, Uwe <br/><br/>
GABAA receptor subtypes: Therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autism.  [electronic resource] 

 -  Annual review of pharmacology and toxicology  2014 
 - 483-507 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review 
<br/><br/><label>ISSN: </label>1545-4304 
<br/><br/><label>Standard No.: </label>10.1146/annurev-pharmtox-011613-135947  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Autistic Disorder--therapy<br/>Brain--metabolism<br/>Clinical Trials as Topic<br/>Cognition--physiology<br/>Disease Models, Animal<br/>Down Syndrome--therapy<br/>Humans<br/>Memory--physiology<br/>Molecular Targeted Therapy<br/>Mood Disorders--therapy<br/>Receptors, GABA-A--metabolism<br/>Schizophrenia--therapy